Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Roger Adami

Roger Adami

Chief Technology Officer Land Therapeutics

Seminars

Monday 20th July 2026

Chair’s Opening Remarks

8:50 am

Monday 20th July 2026

Chair’s Closing Remarks

3:00 pm

Roger Adami - 6th mRNA-Based Therapeutics Summit Speaker

View all Speakers

View Event Brochure